Cargando…
Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study
BACKGROUND: Despite the importance of hepatitis B virus (HBV) immunization in kidney transplantation (KT), data are lacking on fluctuations in hepatitis B surface antibody (anti-HBsAb) levels and optimal levels for KT recipients. METHODS: The study consisted of anti-HBsAb-positive recipients aged 18...
Autores principales: | Chancharoenthana, Wiwat, Leelahavanichkul, Asada, Udomkarnjananun, Suwasin, Wattanatorn, Salin, Avihingsanon, Yingyos, Praditpornsilpa, Kearkiat, Tungsanga, Kriang, Eiam-Ong, Somchai, Townamchai, Natavudh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330517/ https://www.ncbi.nlm.nih.gov/pubmed/30697573 http://dx.doi.org/10.1093/ofid/ofy342 |
Ejemplares similares
-
Alteration of urinary neutrophil gelatinase–associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation
por: Chancharoenthana, Wiwat, et al.
Publicado: (2018) -
Plasmapheresis Reduces Mycophenolic Acid Concentration: A Study of Full AUC(0–12) in Kidney Transplant Recipients
por: Piyasiridej, Sudarat, et al.
Publicado: (2019) -
A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2021) -
Comparison of Tacrolimus Intra-Patient Variability during 6–12 Months after Kidney Transplantation between CYP3A5 Expressers and Nonexpressers
por: Nuchjumroon, Almas, et al.
Publicado: (2022) -
Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2021)